Quick Takeaways
- This page summarizes Nir Sassi's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 29 Dec 2025, 16:01.
Nir Sassi - 22 Dec 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Signature
- /s/ Nir Sassi
- Issuer symbol
- INDP
- Transactions as of
- 22 Dec 2025
- Net transactions value
- +$54,319
- Form type
- 4
- Filing time
- 29 Dec 2025, 16:01:23 UTC
- Previous filing
- 11 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nir Sassi filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 29 Dec 2025."
What Changed
- Previous filing in this sequence was filed on 11 Apr 2025.
- Current net transaction value: +$54,319.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sassi Nir | Chief Financial Officer | C/O INDAPTUS THERAPEUTICS, INC, 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK | /s/ Nir Sassi | 29 Dec 2025 | 0001760673 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INDP | Common Stock | Award | $54,319 | +26,758 | $2.03 | 26,758 | 22 Dec 2025 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The Reporting Person acquired 26,758 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025. |